Welcome to our dedicated page for Unusual Machines SEC filings (Ticker: UMAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Unusual Machines's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Unusual Machines's regulatory disclosures and financial reporting.
UMAC insider Brian Joseph Hoff has filed a notice of proposed sale of company common stock under Rule 144. The filing indicates an intention to sell 75,000 shares of common stock through broker Maxim Group on the NYSE American, with an aggregate market value of $816,000. The filing notes that 37,565,276 shares of the issuer’s common stock were outstanding.
The shares to be sold come from 100,000 common shares acquired on 02/03/2025 as restricted stock units from the issuer, designated as compensation, with a payment date of 12/12/2025. The insider also reported a prior sale during the past three months of 8,750 common shares on 11/20/2025 for gross proceeds of $79,625.
UMAC insider Andrew Ross Camden has filed a notice of proposed sale under Rule 144 to sell 50,000 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $544,000. The filing reports that 37,565,276 shares of the issuer’s common stock are outstanding, providing context for the size of the planned sale.
The shares to be sold come from 100,000 restricted stock units acquired from the issuer on 02/03/2025 as compensation, with the payment date listed as 12/12/2025. The notice also discloses that Camden sold 8,750 common shares on 11/20/2025 for gross proceeds of $79,625 during the past three months, as required by Rule 144 aggregation rules.
Unusual Machines, Inc. filed a current report to let investors know it has entered into a strategic supplier agreement with BrooQLy, Inc., which does business as Dynamic Aerospace Systems. Dynamic Aerospace Systems develops next generation unmanned aerial systems for commercial and defense uses, so this relationship is aimed at supporting Unusual Machines’ position in the drone and aerospace market. Details of the agreement itself are provided in a press release dated December 8, 2025, which is included as an exhibit to the report.
Unusual Machines, Inc. reported that its Annual Meeting of Stockholders, which began on December 1, 2025, has been adjourned until December 19, 2025, at 1:00 p.m. ET. The company is using the additional time to solicit more proxy votes so that a quorum can be reached and stockholders can vote on the election of five directors to serve one-year terms until the next annual meeting. This update was communicated through a press release furnished as an exhibit to the current report.
Unusual Machines, Inc. (UMAC) reported insider equity activity by its Chief Operating Officer. On 11/20/2025, the officer received 125,000 shares of restricted common stock at a stated price of $0, increasing his beneficial holdings. On the same date, he sold 8,750 shares of common stock at $9.10 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he beneficially owned 306,000 shares of Unusual Machines common stock directly. The restricted stock grant was approved by the issuer’s Compensation Committee and is described as exempt from Section 16(b) under Rule 16b-3.
Unusual Machines, Inc. (UMAC) director Cristina Colon reported a sale of company stock on a Form 4. On 11/20/2025, she sold 8,268 shares of common stock at a weighted average price of $9.0569 per share in multiple transactions within a price range of $9.01 to $9.10. The sale was made under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell shares according to a preset schedule. After this transaction, Colon beneficially owns 52,712 shares of Unusual Machines common stock directly.
Unusual Machines, Inc. (UMAC) reported insider activity by its Chief Financial Officer, Brian Hoff. On 11/20/2025, he received a grant of 125,000 shares of restricted common stock at a stated price of $0, bringing his beneficial holdings higher before a same-day sale. Also on 11/20/2025, he sold 8,750 shares of common stock at $9.10 per share, and after these transactions he beneficially owned 490,475 shares, held directly. The restricted stock grant was approved by the issuer’s Compensation Committee under Rule 16b-3, and the sale was executed under a pre-established Rule 10b-5 trading plan administered by an independent third party.
Unusual Machines, Inc. (UMAC) reported an insider equity award to its Chief Executive Officer and director, Allan Evans. On 11/20/2025, Evans, through 8 Consulting LLC, received a grant of 250,000 shares of restricted common stock at a price of $0 per share, approved by the company’s Compensation Committee under Rule 16b-3.
Following this grant, Evans beneficially owns 1,203,650 shares indirectly through 8 Consulting LLC and 110,789 shares directly of Unusual Machines common stock. Evans is the sole owner of 8 Consulting LLC and holds voting and dispositive control over its holdings.
UMAC has a Form 144 filing indicating that a holder plans to sell 10,000 shares of common stock through broker Maxim Group on the NYSE, with an aggregate market value of $91,000. The table shows 36,875,549 shares of common stock outstanding, providing context for the planned sale size.
The securities to be sold were acquired as restricted stock units from the issuer as compensation. One grant covers 8,334 shares dated 05/19/2025 and another covers 2,308 shares dated 08/19/2025, with payment noted as compensation on 11/20/2025. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
UMAC filed a Form 144 notice indicating that shareholder Andrew Ross Camden may sell up to 8,750 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $77,700.00. The filing notes that 36,875,549 shares of common stock were outstanding.
Camden previously acquired 100,000 shares of common stock on 02/03/2025 via restricted stock units from the issuer as compensation, with a payment date of 11/20/2025. Over the past three months, he sold 8,750 shares for $85,468.00 on 08/20/2025 and 35,000 shares for $356,187.00 on 08/21/2025.